Essential Recombinant Cynomolgus Pvrig (c-6his) - Today Only [7tBIsfVX]

Essential Recombinant Cynomolgus Pvrig (c-6his) - Today Only [7tBIsfVX]: A Cutting-Edge Biotechnology Product

Introducing our premium Essential Recombinant Cynomolgus Pvrig (c-6his) - Today Only [7tBIsfVX], a state-of-the-art biotechnology product designed for advanced research applications. This recombinant protein, expressed in HEK293 cells, offers high purity and stability, making it an ideal choice for various experimental setups. With its specific C-His tag, this product is easily detectable and quantifiable, enhancing the efficiency of your research.

Key Product Properties and Specifications

Our Essential Recombinant Cynomolgus Pvrig (c-6his) - Today Only [7tBIsfVX] boasts an impressive purity of over 95%, ensuring reliable and consistent results. It has a calculated molecular weight of 14.5 kDa and an observed molecular weight ranging from 20-30 kDa, which is indicative of its high quality and purity. The product is formulated in a PBS buffer with added protectants like trehalose, mannitol, and Tween 80, ensuring stability and ease of use. Below are some of the key properties and specifications:

• Purity: > 95% as determined by reducing SDS-PAGE.
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
• Storage: Stable for up to 12 months when stored at -20 to -80℃.
• Shipping: Provided as lyophilized powder with ice packs for safe delivery.

Applications and Benefits in Research

Our Essential Recombinant Cynomolgus Pvrig (c-6his) - Today Only [7tBIsfVX] is a versatile tool for researchers studying the PVRIG protein and its role in immune responses. This product is particularly useful for exploring the interaction between PVRIG and Nectin-2/CD112, which has implications in immune checkpoint therapies. By disrupting the PVRIG/Nectin-2 interaction, researchers can enhance human T cell responses, opening new avenues for immunotherapy development. This product is suitable for a wide range of applications, including:

• Immunology research
• Immunotherapy development
• Cell signaling studies